Highly immunostimulatory CpG-free oligodeoxynucleotides for activation of human leukocytes

Antisense and Nucleic Acid Drug Development

Volumn 12, Issue 3, 2002, Pages 165-175

  Vollmer, Jörg ^a   Janosch, Andrea ^a   Laucht, Meike ^a   Ballas, Zuhair K ^b,c   Schetter, Christian ^a   Krieg, Arthur M ^a,b,c  

^a PFIZER INC   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; CYTOSINE; GUANOSINE; IMMUNOSTIMULATING AGENT; OLIGODEOXYNUCLEOTIDE DERIVATIVE; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; THYMIDINE; OLIGODEOXYRIBONUCLEOTIDE;

ARTICLE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; LEUKOCYTE ACTIVATION; PRIORITY JOURNAL; CELL CULTURE; CHEMISTRY; DRUG EFFECT; FLOW CYTOMETRY; IMMUNOLOGY; LEUKOCYTE; NUCLEOTIDE SEQUENCE;

BACTERIA (MICROORGANISMS); OTHER SEQUENCES; VERTEBRATA;

BASE SEQUENCE; CELLS, CULTURED; CPG ISLANDS; FLOW CYTOMETRY; HUMANS; LEUKOCYTES; OLIGODEOXYRIBONUCLEOTIDES; THYMIDINE;

EID: 0035992664     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/108729002760220761     Document Type: Article

References (44)

1. Induction of natural killer activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA
2. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition
3. Characterization and modulation of immune stimulation by modified oligonucleotides
4. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen
5. Effect of CpG methylation on isotype and magnitude responses to influenza hemagglutinin-expressing plasmid
6. Multivalent cross-linking of membrane Ig sensitizes murine B cells to a broader spectrum of CpG-containing oligodeoxynucleotide motifs, including their methylated counterparts, for stimulation of proliferation and Ig secretion
7. Immune response to a hepatitis B DNA vaccine in Aotus monkeys: A comparison of vaccine formulation, route, and method of administration
8. CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation
9. In vitro inhibition of murine IFN-γ production by phosphorothioate deoxyguanosine oligomers
10. Mechanism and function of a newly identified CpG DNA motif in human primary B cells
11. Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo
12. CpG DNA as a signal for growth, activation and maturation of human dendritic cells
13. Inhibition of interferon-γ-induced intercellular adhesion molecule-I expression on human keratinocytes by phosphorothioate antisense oligodeoxynucleotides is the consequence of antisense-specific and antisense-nonspecific effects
14. + dendritic cells to produce type I IFN
15. Binding of oligoguanylate to scavenger receptors is required for oligonucleotides to augment NK cell activity and induce IFN
16. CpG motifs in bacterial DNA trigger direct B cell activation
17. CpG motifs in bacterial DNA and their immune effects
18. Oligodeoxynucleotide modifications determine the magnitude of immune stimulation by CpG motifs
19. Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs
20. Identification of CpG oligonucleotide sequences with high induction of IFN-a/b in plasmacytoid dendritic cells
21. CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleotides at a site proximal in NF-κB activation
22. Activation of human B cells by phosphorothioate oligodeoxynucleotides
23. Bacterial DNA as immune cell activator
24. Stimulation of thymocyte proliferation by phosphorothioate oligonucleotides
25. 3H-thymidine incorporation by control oligonucleotides
26. The potential of oligodeoxynucleotides as mucosal and parenteral adjuvants
27. Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA
28. Immune stimulation - A class effect of phosphorothioate oligodeoxynucleotides in rodents
29. Influence of backbone chemistry on immune activation by synthetic oligonucleotides
30. Characterization of the oligodeoxynucleotide-mediated inhibition of interferon-γ-induced major histocompatibility complex class I and intercellular adhesion molecule-1
31. Inhibition of interferon-γ-induced major histocompatibility complex class I expression by certain oligodeoxynucleotides
32. DNA from protozoan parasites B. bovis, T. cruzi and T. brucei is mitogenic for B lymphocytes and stimulates macrophage expression of interleukin-12, tumor necrosis factor alpha, and nitric oxide
33. Bias in nucleotide composition of antisense oligonucleotides
34. Antisense oligonucleotides as therapeutic agents - Is the bullet really magical?
35. Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis GCG. I. Isolation, physicochemical characterization, and antitumor activity
36. A synthetic single-stranded DNA, poly(dG,dC), induces interferon-α/β and -γ, augments natural killer activity, and suppresses tumor growth
37. Antisense oligodeoxyribonucleotides suppress hematologic cell growth through stepwise release of deoxyribonucleotides
38. Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization
39. The influence of DNA sequence on the immunostimulatory properties of plasmid DNA vectors
40. Lipofection of synthetic oligodeoxyribonucleotide having a palindromic sequence of AACGTT to murine splenocytes enhances interferon production and natural killer activity
41. CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry
42. Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides
43. Effect of different chemically modified oligodeoxynucleotides on immune stimulation